Published in Int Psychogeriatr on January 01, 1997
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (2000) 4.37
Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry (1976) 2.30
Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet (1992) 2.18
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 1.81
Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature (1991) 1.72
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain (1996) 1.64
[Consensus recommendations for the assessment of fitness to drive in cognitively impaired patients]. Praxis (Bern 1994) (2012) 1.55
KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet (2000) 1.53
The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression? Arch Gen Psychiatry (1989) 1.49
Intussusception in adults. Mt Sinai J Med (2000) 1.47
Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology (1995) 1.42
[Mild cognitive impairment with predictors of rapid decline]. Dtsch Med Wochenschr (2008) 1.39
PULMONARY INFARCTION AND EMBOLISM. Ann Surg (1929) 1.37
Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita. Hum Mol Genet (1994) 1.22
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20
Encysted peritoneal hydatidosis in a child -- the effectiveness of pre-operative therapy with a combination of praziquantel and albendazole. Ann Trop Med Parasitol (2005) 1.16
Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud Health Technol Inform (2000) 1.15
First record of breeding populations of Aedes albopictus in continental Africa: implications for arboviral transmission. J Am Mosq Control Assoc (1992) 1.13
An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood (1984) 1.12
Folstein vs modified Mini-Mental State Examination in geriatric stroke. Stability, validity, and screening utility. Arch Neurol (1995) 1.11
Acute respiratory infections in Nigerian children: prospective cohort study of incidence and case management. J Trop Pediatr (1994) 1.09
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiatry (2001) 1.05
SMN gene deletion in variant of infantile spinal muscular atrophy. Lancet (1995) 1.05
Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years. Int J Clin Pract (2005) 1.04
Progress and problems in muscle glycogenoses. Acta Myol (2011) 1.04
Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease. Int J Geriatr Psychiatry (2004) 0.98
Evaluation of diagnostic scores with adjustment for covariates. Stat Med (2008) 0.97
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit. J Neural Transm (Vienna) (2002) 0.96
Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency. Am J Hum Genet (1995) 0.96
A retrospective study of diagnosis and management of mesenteric vein thrombosis. Am J Surg (2001) 0.95
Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol B Psychol Sci Soc Sci (1995) 0.93
Deletion breakpoints associated with the Prader-Willi and Angelman syndromes (15q11-q13) are not sites of high homologous recombination. Hum Genet (1993) 0.93
Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis. J Geriatr Psychiatry Neurol (2005) 0.93
Random number generation in dementia of the Alzheimer type: a test of frontal executive functions. Neuropsychologia (1996) 0.91
Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol (1979) 0.90
Validation of the NOSGER (Nurses' Observation Scale for Geriatric Patients): reliability and validity of a caregiver rating instrument. Int Psychogeriatr (1996) 0.90
The influence of anxiety and pain sensitivity on experimental pain in man. Pain (1978) 0.89
Dementia with lewy bodies: findings from an international multicentre study. Int J Geriatr Psychiatry (2000) 0.87
Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor. Ann N Y Acad Sci (1991) 0.86
Argyrophilic grain disease: distribution of grains in patients with and without dementia. Acta Neuropathol (1997) 0.86
Improving the diagnostic accuracy of the Mini-Mental State Examination. Acta Neurol Scand (1995) 0.86
Prenatal prediction of Werdnig-Hoffmann disease using linked polymorphic DNA probes. J Med Genet (1992) 0.86
Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study. Int Psychogeriatr (1992) 0.85
Screening for dementia of the alzheimer type in the community: the utility of the Clock Drawing Test. Arch Clin Neuropsychol (1996) 0.84
Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis. Mult Scler (2008) 0.84
[Familial giant hemangiomas of the liver. Study of a family and review of the literature]. Praxis (Bern 1994) (1998) 0.84
Human EEG slow-wave sleep increased by a serotonin antagonist. Electroencephalogr Clin Neurophysiol (1982) 0.84
CT of American Burkitt lymphoma. AJR Am J Roentgenol (1981) 0.83
Parental origin of the supernumerary chromosome in trisomy 18. Clin Genet (1993) 0.83
Discrimination of cortical from subcortical dementias on the basis of memory and problem-solving tests. J Clin Psychol (1995) 0.83
Age-dependent phenotypic expression of a pattern dystrophy of the retina. Eur J Ophthalmol (1995) 0.82
Weight change and cognitive performance. Int J Obes Relat Metab Disord (2004) 0.82
Significance of slow wave sleep: considerations from a clinical viewpoint. Sleep (1986) 0.82
Repetitive behavior and repetition avoidance: the role of the right hemisphere. J Psychiatry Neurosci (1996) 0.81
Psychiatric symptoms and CAG expansion in Huntington's disease. Am J Med Genet (1996) 0.80
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. Alzheimer Dis Assoc Disord (1997) 0.80
A PCR based X-chromosome inactivation assay for carrier detection in X-linked immunodeficiencies using differential methylation of the androgen receptor gene. Immunodeficiency (1995) 0.80
Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects. Br J Clin Pharmacol (1980) 0.80
Critical review of clinical trials in senile dementia--II. Postgrad Med J (1987) 0.80
Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man. Neuropsychopharmacology (1993) 0.80
Category fluency is also predominantly affected in Swiss Alzheimer's disease patients. Acta Neurol Scand (1997) 0.80
Genetic heterogeneity in autosomal dominant pattern dystrophy of the retina. Mol Vis (1996) 0.80
Effects of amphetamines on performance and on polygraphic sleep parameters in man. Adv Biosci (1979) 0.79
Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease. Clin Neurophysiol (2013) 0.79
[Argyrophilic grain disease: differentiation from Alzheimer disease]. Pathologe (1999) 0.79
[Pharmacotherapy of central oculomotor disorders]. Nervenarzt (2008) 0.79
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. Eur J Neurol (2004) 0.79
[Conviction as a basis for compliance and strategies for improving compliance]. Schweiz Med Wochenschr (1999) 0.79
Apolipoprotein E allele frequencies in argyrophilic grain disease. Acta Neuropathol (1998) 0.78
Muscarinic agonists for senile dementia: past experience and future trends. Trends Pharmacol Sci (1989) 0.78
Longitudinal mixing in pulmonary airways--normal subjects respiring at a constant flow. J Appl Physiol Respir Environ Exerc Physiol (1978) 0.78
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT). Psychopharmacology (Berl) (1984) 0.78
Argyrophilic grain disease. A frequent dementing disorder in aged patients. Adv Exp Med Biol (2001) 0.78
Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects. Neuropsychopharmacology (1993) 0.77
The effect of zoledronic acid on the fracture risk in men with osteoporosis. J Endocrinol Invest (2014) 0.76
Polygraphic sleep studies in rats and humans: their use in psychopharmacological research. Arzneimittelforschung (1976) 0.76
Assessment of dementia in elderly outpatients: a comparative study of European centers and consensus statement. Arch Gerontol Geriatr (2004) 0.76
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. Cancer Treat Rep (1986) 0.76
Cystic fibrosis associated with neuronal intestinal dysplasia type B: a case report. J Pediatr Surg (1996) 0.75
Correlations between triplet repeat expansion and clinical features in Huntington's disease. Arch Neurol (1996) 0.75
EEG and sleep in aged hospitalized patients with senile dementia: 24-h recordings. Experientia (1983) 0.75
Turning principles into practice in Alzheimer's disease. Int J Clin Pract (2010) 0.75
Effects of RS 86, an orally active cholinergic agonist, on sleep in man. Psychiatry Res (1984) 0.75
Cognitive aspects of affects and other feeling states with clinical applications. J Am Acad Psychoanal (1980) 0.75
A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years. Gerontology (1984) 0.75
Survival, psychoanalysis and the Third Reich. J Am Acad Psychoanal (1985) 0.75
Aspects of sleep, daytime vigilance, mental performance and psychotropic drug treatment in the elderly. Gerontology (1982) 0.75
A controlled long-term study with ergoloid mesylates (Hydergine) in healthy, elderly volunteers: results after three years. J Am Geriatr Soc (1983) 0.75
[Sleep disorders in the aged]. Internist (Berl) (1984) 0.75
[Occult bacteremia in children--an old syndrome, new approaches]. Harefuah (1999) 0.75
Action of lysine-vasopressin on human electroencephalographic activity. Night sleep pattern, auditory evoked potential, contingent negative variation. Neuropsychobiology (1982) 0.75
On predicting therapeutic usefulness of psychotropic drugs from experiments in health persons. Rev Pure Appl Pharmacol Sci (1981) 0.75
[Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)]. Pharmakopsychiatr Neuropsychopharmakol (1980) 0.75
Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep. Brain Res (1980) 0.75
[Effect of non-prescription soporific on the sleep polygram of healthy volunteers]. Schweiz Rundsch Med Prax (1984) 0.75
[Rorschach test findings in two groups of patients with rheumatic diseases (ankylosing spondylitis--lumbar herniated disk)]. Z Exp Angew Psychol (1969) 0.75
[Prediction of treatment outcome with antidepressants: are short REM latencies diagnostically and prognostically reliable indicators?]. Fortschr Neurol Psychiatr (1984) 0.75